USPTO serial 88502697
PENTAPHARM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 12, 2021
- Examiner
- CORDOVA,RAUL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with PENTAPHARM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,446*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Duane M. Byers
Duane M. Byers NIXON & VANDERHYE PC901 N. GLEBE ROAD, 11TH FLOORARLINGTON, VA 22203UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for industrial and scientific purposes, in particular for use in the manufacture of pharmaceutical agents; chemical substances for analyses in laboratories and chemical preparations for scientific purposes; diagnostic preparations for scientific or research use other than for medical use; chemical and biochemical products for the pharmaceutic, cosmetic industries; raw materials for use in the manufacture of pharmaceuticals, namely, raw chemical materials for the formulation of pharmaceutical products | ACTIVE | — |
| 003 | Cosmetics, also for beauty and skin care; Cosmetic preparations and substances for the conditioning, caring and appearance of the skin, body, face and hair; cosmetics and skin care products for the prevention of sunburn; sun-tan and sun-screening preparations | ACTIVE | — |
| 005 | Pharmaceutical preparations for use in dermatology, and pharmaceutical preparations, namely, polypeptide fractions of porcine collagen for use in protein stabilization and for use in tissue culture and cell culture; reagents and diagnostic preparations for medical purposes; diagnostic preparations for clinical or medical laboratory use; chemical preparations for pharmaceutical or medical purposes; chemical pharmaceuticals; diagnostic products for medical or veterinary purposes, namely, diagnostic products to measure blood coagulations; diagnostic test kits used for medical analysis of blood | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, testing apparatus and diagnostic equipment for medical purposes to measure blood coagulation and to diagnosis blood coagulation disorders; measuring devices and diagnostic equipment for medical purposes, namely, blood glucose measuring equipment, blood pressure measuring instrument | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DSM IP Assets B.V.
- Other trademarks owned by PENTAPHARM AG
- Other trademarks owned by DSM IP Assets B.V.
- Other trademarks owned by DSM IP Assets B.V.
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named PENTAPHARM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 12, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 1, 2023 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jan 12, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 27, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 27, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 7, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 22, 2020 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Sep 18, 2020 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Sep 12, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 31, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 31, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 20, 2020 | ALIE | ASSIGNED TO LIE | — |
| Aug 2, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 11, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 11, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 11, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 4, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 3, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 3, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 3, 2019 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 3, 2019 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 3, 2019 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Sep 24, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 16, 2019 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jul 15, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 10, 2019 | NWAP | NEW APPLICATION ENTERED | — |